Arrowhead Pharmaceuticals
ARWR
#2176
Rank
$8.49 B
Marketcap
$61.44
Share price
-4.98%
Change (1 day)
160.23%
Change (1 year)

Market capitalization of Arrowhead Pharmaceuticals (ARWR)

Market cap: $8.49 Billion USD

As of December 2025 Arrowhead Pharmaceuticals has a market cap of $8.49 Billion USD. This makes Arrowhead Pharmaceuticals the world's 2176th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Arrowhead Pharmaceuticals from 1997 to 2025

End of year Market Cap

Year Marketcap Change
2025$8.49 B260.05%
2024$2.35 B-28.23%
2023$3.28 B-28.79%
2022$4.61 B-33.39%
2021$6.93 B-12.11%
2020$7.88 B22.94%
2019$6.41 B457.7%
2018$1.14 B317.62%
2017$0.27 B139.52%
2016$0.11 B-68.65%
2015$0.36 B-9.19%
2014$0.40 B-4.58%
2013$0.42 B1164.02%
2012$33.47 M-24.09%
2011$44.1 M-31.37%
2010$64.26 M93.12%
2009$33.27 M-15.75%
2008$39.49 M-73.01%
2007$0.14 B-2.4%
2006$0.14 B5.07%
2005$0.14 B134.03%
2004$60.97 M57631.68%
2003$0.1 M233.72%
2002$0.03 M-60%
2001$0.07 M-75.3%
2000$0.32 M27.72%
1999$0.25 M-4.78%
1998$0.26 M64.95%
1997$0.15 M

End of Day market cap according to different sources

On Dec 6th, 2025 the market cap of Arrowhead Pharmaceuticals was reported to be:

$8.34 Billion USD
by Nasdaq info icon info icon
$8.49 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Alnylam Pharmaceuticals
ALNY
$60.52 B 612.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
$2.97 B-64.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$3.63 B-57.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
$0.14 B-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
$486.50 B 5,627.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
$10.82 B 27.41%๐Ÿ‡บ๐Ÿ‡ธ USA